Homeinvesting in healthcare mutual funds

investing in healthcare mutual funds

Gilead & Galapagos’ RA Drug Receives Approval in Europe

Gilead & Galapagos’ RA Drug Receives Approval in Europe

September 28, 2020

Blueprint Medicines’ Gist Drug Ayvakyt Gets EU Approval

Blueprint Medicines’ Gist Drug Ayvakyt Gets EU Approval

September 28, 2020

Vertex’s Kalydeco Gets FDA Nod for Cystic Fibrosis in Infants

Vertex’s Kalydeco Gets FDA Nod for Cystic Fibrosis in Infants

September 28, 2020

Galapagos Gets First Commercial Drug With Jyseleca Approval

Galapagos Gets First Commercial Drug With Jyseleca Approval

September 28, 2020

How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks – September 28, 2020

How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks – September 28, 2020

September 28, 2020

Unprecedented Global Turmoil Underlines Need for Effective Diagnostics

Unprecedented Global Turmoil Underlines Need for Effective Diagnostics

September 28, 2020

The Zacks Analyst Blog Highlights: Anheuser-Busch InBev, Gilead Sciences, Canadian National Railway, Stryker Corp and Goldman Sachs

The Zacks Analyst Blog Highlights: Anheuser-Busch InBev, Gilead Sciences, Canadian National Railway, Stryker Corp and Goldman Sachs

September 28, 2020

Glaxo Gets FDA Nod for Nucala for Hypereosinophilic Syndrome

Glaxo Gets FDA Nod for Nucala for Hypereosinophilic Syndrome

September 28, 2020

Bristol-Myers’ Opdivo Meets Goals in Bladder Cancer Study

Bristol-Myers’ Opdivo Meets Goals in Bladder Cancer Study

September 25, 2020

The Zacks Analyst Blog Highlights: JNJ, Pfizer, AstraZeneca, Sanofi and GSK

The Zacks Analyst Blog Highlights: JNJ, Pfizer, AstraZeneca, Sanofi and GSK

September 25, 2020

« 1 … 379 380 381 382 383 … 449 »